Rachael Brandt is a certified genetic counselor and the coordinator of the Cancer Risk Assessment and Genetics Program for Main Line Health Lankenau and Bryn Mawr Hospitals.
Rachael is dedicated to supporting women and families at risk for hereditary breast cancer. To this end, she founded a face-to-face networking group for women with BRCA1 or BRCA2 mutations called AWARE (Answers for Women At Risk will Empower).
In addition, Rachael has co-authored several papers and abstracts related to cancer genetics services, breast cancer risk perception, and motivations and concerns among women seeking genetic testing for breast cancer.
After graduating with a B.S. in biology from Davidson College, Rachael joined the Institute for Genomic Research as a research and development team member. In addition, she also served within the Genetic Alliance. Upon graduating with an M.S. in genetic counseling from Arcadia University, Rachael began providing cancer genetics consultations under the direction of an internationally known pioneer within the cancer genetics field and has held an adjunct faculty position at Northwestern University. She is currently pursuing a Ph.D. in counseling from the George Washington University to further her ability to support individuals with cancer and inherited cancer risk.
"It is an honor to serve on the Professional Advisory Board of Breastcancer.org. I hope to educate women about breast cancer genetics so they have the tools to determine if they or their family members may be at risk. Knowing risk is the first step in breast cancer prevention."
Can we help guide you?
Create a profile for better recommendations
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
What Is Breast Implant Illness?
Breast implant illness (BII) is a term that some women and doctors use to refer to a wide range...